Shannise Brown

Shannise Brown has a diverse work experience in the pharmaceutical industry. Shannise is currently working as the Head Global Market Access Gene Therapy at Astellas Gene Therapies since August 2021. Prior to this, they held the position of Senior Director Global Pricing & Market Access Lead HIV/Inflammation at Gilead Sciences from April 2014 to July 2021. Shannise also worked as the Manager Global Pricing at Merck from May 2012 to April 2014, and as the Manager Customer Business Strategy-Consultant at Bayer HealthCare from July 2011 to December 2011. Before that, they served as an Associate Consultant Managed Markets at inVentiv Health from November 2010 to April 2011. Shannise started their career as a Market Analytics & Competitive Intelligence at PDI, Inc. from September 2007 to October 2010, and also worked as a Sales & Marketing Financial Analyst at Eisai from August 2005 to September 2007. Shannise began their career at Pfizer, where they worked as an R&D Budget Analyst from January 2003 to July 2005, and as a Vaccines Coordinator/Clinical Analyst from June 2001 to December 2002.

Shannise Brown obtained their Bachelor of Science (BS) degree in Physical & Medical Anthropology from the University at Buffalo. Shannise attended the university from 1995 to 2000.